MedTrace Logo

Predicts Mortality by AST/ALT Ration in Patients with Sepsis and Septic Shock During ICU Admissin

NCT06683794 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 142

Last updated 2024-11-12

No results posted yet for this study

Summary

1\_The study predicts mortality by using Asparate aminotransferase (AST) to Alanine aminotransferase (ALT) ratio in patients with sepsis and septic shock during the duration of ICU admission and for one month after discharge.

2- Compare between APACHE II and AST/ALT ratio as prognostic factors in patients with sepsis and septic shock.

Conditions

  • E Prognostic Value of the AST/ALT Ratio Vs. APACHE II Score in Patients with Sepsis and Septic Shock

Sponsors & Collaborators

  • Nermeen Gamil Ahmed

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-11-01
Completion
2025-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06683794 on ClinicalTrials.gov